SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-22-021888
Filing Date
2022-04-27
Accepted
2022-04-27 15:53:39
Documents
2
Group Members
DIANA ELIZABETH RANDALLKENNETH EDWARD RANDALLMARK EDWARD RANDALL

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea158951-sc13drenais_tcbio.htm SC 13D 126736
2 JOINT FILING AGREEMENT ea158951ex99-1_tcbio.htm EX-99.1 5901
  Complete submission text file 0001213900-22-021888.txt   134399
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) plc (Subject) CIK: 0001872812 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93570 | Film No.: 22859362
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 42 SHAD THAMES LONDON X0 SE1 2YD
Business Address 42 SHAD THAMES LONDON X0 SE1 2YD 0044(0)2073979625
Renaissance Capital Partners Ltd (Filed by) CIK: 0001920179 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13D